View of CRISPR-Cas9 as a gene editing tool using cardiac glycoside reductase operon for digoxin metabolism

Return to Issue Details CRISPR-Cas9 as a gene editing tool using cardiac glycoside reductase operon for digoxin metabolism Download Download PDF